David W. Markby
Impact in
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Biochemical and Molecular Research 4
-
- Renal cell carcinoma treatment 6
- Co-authors
- Henry R. Bourne (3 shared papers)H. K. Schachman (5 shared papers)René Onrust (1 shared paper)Edward Eisenstein (2 shared papers)James Newell (1 shared paper)Susan R. Wente (1 shared paper)Ying Yang (1 shared paper)Andrew Flint (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Proceedings of the National Academy of Sciences (3 papers)Biochemistry (2 papers)Clinical Cancer Research (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
David W. Markby
15 papers receiving 471 citations
Peers
Comparison fields: 5 of 54
- Biochemistry 68
- Hepatology 64
- Clinical Biochemistry 55
- Cell Biology 109
- Molecular Biology 265
Countries citing papers authored by David W. Markby
This map shows the geographic impact of David W. Markby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Markby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Markby more than expected).
Fields of papers citing papers by David W. Markby
This network shows the impact of papers produced by David W. Markby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Markby. The network helps show where David W. Markby may publish in the future.
Co-authors
The 25 scholars most cited alongside David W. Markby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 145 | |
| 2 | 2020 | 66 | |
| 3 | 2018 | 66 | |
| 4 | 1990 | 43 | |
| 5 | 1989 | 41 | |
| 6 | 1986 | 34 | |
| 7 | 1989 | 31 | |
| 8 | 1995 | 14 | |
| 9 | 1991 | 12 | |
| 10 | 2018 | 9 | |
| 11 | 2019 | 7 | |
| 12 | 1995 | 4 | |
| 13 | 2019 | 3 | |
| 14 | 2017 | 1 | |
| 15 | 2018 | 1 |
About David W. Markby
David W. Markby is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology, Clinical Biochemistry and Hepatology, having authored 15 papers that have together received 477 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Hemoglobin structure and function (4 papers), Biochemical and Molecular Research (4 papers), Enzyme Structure and Function (3 papers), Metabolism and Genetic Disorders (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Biochemistry (68 citations), Hepatology (64 citations), Clinical Biochemistry (55 citations), Cell Biology (109 citations) and Molecular Biology (265 citations). David W. Markby has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Henry R. Bourne, H. K. Schachman, René Onrust, Edward Eisenstein, James Newell, Susan R. Wente, Ying Yang, Andrew Flint, Ellen A. Robey and Robin Kate Kelley. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Biochemistry, Clinical Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.